Description
Serplulimab is a recombinant humanized IgG4 monoclonal antibody targeting PD-1. By inhibiting PD-1 signaling, it enhances antitumor immunity and promotes T-cell activation against cancer cells.
Target
PD-1
Target Alias Names
CD279, PD1, PDCD1, Programmed cell death protein 1, Protein PD-1, hPD-1
Isotypes/Mimetics
IgG4, kappa
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Unknown
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression